Miao Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miao Yang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Wei Xu
Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China
3 shared publications - Dong-Hui Huang
Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China
2 shared publications - Haoran Du
Department of Pediatrics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning 110004, China
2 shared publications - Jingli Yan
Department of Pediatrics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning 110004, China
2 shared publications Biying Zhao
State Key Laboratory of Advanced Optical Communication Systems and Networks, School of Electronics, and Center for Quantum Information Technology, Peking University
1 shared publicationBo Wu
Department of Pediatric, Shengjing Hospital of China Medical University
1 shared publication
Latest Publications
- Open Access
- 26 August 2026
- Published by Elsevier in SSRN Electronic Journal
Prenatal Temperature Exposure And Cross-Classified BMI–Depressive Symptom Trajectory Phenotypes From Childhood To Adolescence: A Longitudinal Cohort Study In China
Background: Prenatal ambient temperature exposure has been linked to early growth outcomes, but evidence on later BMI-related developmental patterns remains limited. We examined associations between multidimensional prenatal temperature exposure and cross-classified BMI-for-age–depressive symptom trajectory phenotypes from childhood to adolescence.Methods: We included 2639 participants from seven waves (2010–2022) in the China Family Panel Studies with repeated height, weight and depressive symptom assessments. BMI-for-age and depressive symptom trajectories were identified separately using latent class growth analysis and cross-classified into six phenotypes. County-level prenatal temperature exposure was assessed using eight metrics capturing extreme temperature frequency, variability, and intensity. Multinomial logistic regression with multiple imputation was used to estimate relative risk ratios (RRRs).Findings: Cold rate showed the most consistent association with BMI-related phenotypes. Compared with Q1, the Q2, Q3, and Q4 categories of cold rate were associated with higher RRRs for the high BMI-for-age + low depressive symptom phenotype: 1·723 (95% CI: 1·216, 2·440), 1·678 (95% CI: 1·131, 2·491), and 2·251 (95% CI: 1·437, 3·526), respectively. The Q4 versus Q1 association remained significant after FDR correction (q = 0·047) and a positive trend was also observed (P for trend = 0·001). Sensitivity analyses generally supported this pattern.Interpretation: Recurrent extreme cold exposure during pregnancy was associated with later BMI-related developmental heterogeneity, highlighting the need for attention in maternal–child environmental health protection.Funding: 2025 Special Research Project of the Capacity Building and Continuing Education Center of National Health Commission; National Natural Science Foundation of China.
- 26 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPrenatal Temperature Exposure And Cross-Classified BMI–Depressive Symptom Trajectory Phenotypes From Childhood To Adolescence: A Longitudinal Cohort Study In China
Background: Prenatal ambient temperature exposure has been linked to early growth outcomes, but evidence on later BMI-related developmental patterns remains limited. We examined associations between multidimensional prenatal temperature exposure and cross-classified BMI-for-age–depressive symptom trajectory phenotypes from childhood to adolescence.Methods: We included 2639 participants from seven waves (2010–2022) in the China Family Panel Studies with repeated height, weight and depressive symptom assessments. BMI-for-age and depressive symptom trajectories were identified separately using latent class growth analysis and cross-classified into six phenotypes. County-level prenatal temperature exposure was assessed using eight metrics capturing extreme temperature frequency, variability, and intensity. Multinomial logistic regression with multiple imputation was used to estimate relative risk ratios (RRRs).Findings: Cold rate showed the most consistent association with BMI-related phenotypes. Compared with Q1, the Q2, Q3, and Q4 categories of cold rate were associated with higher RRRs for the high BMI-for-age + low depressive symptom phenotype: 1·723 (95% CI: 1·216, 2·440), 1·678 (95% CI: 1·131, 2·491), and 2·251 (95% CI: 1·437, 3·526), respectively. The Q4 versus Q1 association remained significant after FDR correction (q = 0·047) and a positive trend was also observed (P for trend = 0·001). Sensitivity analyses generally supported this pattern.Interpretation: Recurrent extreme cold exposure during pregnancy was associated with later BMI-related developmental heterogeneity, highlighting the need for attention in maternal–child environmental health protection.Funding: 2025 Special Research Project of the Capacity Building and Continuing Education Center of National Health Commission; National Natural Science Foundation of China.
- Open Access
- 9 July 2026
- Published by Elsevier in Environmental Research
- Vol. 306, 125214
Prenatal cold duration and childhood cognitive performance: Evidence from a multifaceted assessment of temperature frequency, variability, and intensity
- 9 July 2026
- Published by Elsevier in Environmental Research
- Vol. 306, 125214
Open AccessPrenatal cold duration and childhood cognitive performance: Evidence from a multifaceted assessment of temperature frequency, variability, and intensity
- 7 April 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (7) , e70502
miR ‐29 inhibits endothelial‐to‐mesenchymal transition in pulmonary hypertension of the newborn by regulating LRP6
Pulmonary hypertension of the newborn (PHN) is a common pulmonary vascular disease in newborns, affecting the prognosis of affected infants and even leading to death. Currently, there is still no specific targeted prevention and treatment program available. In recent years, research on the regulatory mechanism of endothelial‐to‐mesenchymal transition (EndMT) has become a hot topic, with the interplay between miRNAs and the Wnt signaling pathway playing an important role. MiR‐29 is highly expressed in distal pulmonary arteriolar smooth muscle cells and endothelial cells. In miR‐29 gene knockout mice, pathological changes in lung tissue can be observed, indicating an obstruction in the maturation of smooth muscle cells in the distal pulmonary arterioles. LRP6 is an important Wnt co‐receptor in the Wnt signaling pathway, and the Targetscan website predicts a binding site between miR‐29 and LRP6. Therefore, our studies establish a role for decreased miR29a in the endothelial mesenchymal transition through activation of the LRP6‐Wnt signaling pathway in neonatal hypoxia‐mediated PAH. By generating hypoxic newborn rat models of pulmonary artery hypertension and hypoxic injury models of pulmonary vascular endothelial cells, we observed the presence of EndMT in the model group, as well as the activation of the LRP6 and Wnt/β‐catenin signaling pathways and the differential expression of the miR‐29 family, particularly miR‐29a. Subsequently, We used cell transfection technology to overexpress/knock down miR‐29a and LRP6, respectively, to observe changes in EndMT‐related indicators and successfully found that miR‐29a and LRP6 can negatively and positively regulate the occurrence of EndMT, respectively. Finally, the dual‐luciferase reporter gene assay confirmed that LRP6 can directly bind to miR‐29a‐3p. These findings provide experimental evidence of the potential of miR‐29 as a novel target for the prevention and treatment of PHN.
- 7 April 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (7) , e70502
miR ‐29 inhibits endothelial‐to‐mesenchymal transition in pulmonary hypertension of the newborn by regulating LRP6
Pulmonary hypertension of the newborn (PHN) is a common pulmonary vascular disease in newborns, affecting the prognosis of affected infants and even leading to death. Currently, there is still no specific targeted prevention and treatment program available. In recent years, research on the regulatory mechanism of endothelial‐to‐mesenchymal transition (EndMT) has become a hot topic, with the interplay between miRNAs and the Wnt signaling pathway playing an important role. MiR‐29 is highly expressed in distal pulmonary arteriolar smooth muscle cells and endothelial cells. In miR‐29 gene knockout mice, pathological changes in lung tissue can be observed, indicating an obstruction in the maturation of smooth muscle cells in the distal pulmonary arterioles. LRP6 is an important Wnt co‐receptor in the Wnt signaling pathway, and the Targetscan website predicts a binding site between miR‐29 and LRP6. Therefore, our studies establish a role for decreased miR29a in the endothelial mesenchymal transition through activation of the LRP6‐Wnt signaling pathway in neonatal hypoxia‐mediated PAH. By generating hypoxic newborn rat models of pulmonary artery hypertension and hypoxic injury models of pulmonary vascular endothelial cells, we observed the presence of EndMT in the model group, as well as the activation of the LRP6 and Wnt/β‐catenin signaling pathways and the differential expression of the miR‐29 family, particularly miR‐29a. Subsequently, We used cell transfection technology to overexpress/knock down miR‐29a and LRP6, respectively, to observe changes in EndMT‐related indicators and successfully found that miR‐29a and LRP6 can negatively and positively regulate the occurrence of EndMT, respectively. Finally, the dual‐luciferase reporter gene assay confirmed that LRP6 can directly bind to miR‐29a‐3p. These findings provide experimental evidence of the potential of miR‐29 as a novel target for the prevention and treatment of PHN.
- Open Access
Magnetocardiography for the diagnosis of coronary artery disease: a systematic review and meta-analysis
Background: Globally, coronary heart disease (CHD) is a major public health issue because it significantly increases mortality and medical expenses. In the recent years, magnetocardiography (MCG) has shown its potential as a new tool for diagnosing CHD. However, the quantitative assessment of MCG currently used for CHD diagnosis are insufficient, preventing its full integration into routine clinical practice. Methods: We searched PubMed (including MEDLINE), Embase, Web of Science, Cochrane Library, Scopus, China National Knowledge Infrastructure (CNKI), Wanfang Data, and ClinicalTrials.gov for studies published up to March 4, 2023. We systematically searched for studies that compare MCG (as the index test) with coronary angiography (as the standard reference) for diagnosing CHD in suspected population. Three authors assessed the quality of the included studies independently using the QUADAS-2 tool. We calculated the pooled value of the sensitivity and specificity of MCG using the bivariate model. To investigate clinical and methodological factors that might contribute to the statistical heterogeneity, we used meta-regression and subgroup analysis. This systematic review and meta-analysis has been conformed to PRISMA guidelines and registered with PROSPERO (number CRD42022332272). Results: By searching, we found 174 studies, 18 of them included 2,571 subjects from 6 countries and regions and met the inclusion criteria. The combined values for sensitivity and specificity are 86% (95% CI: 80-91) and 79% (95% CI: 71-86), respectively. The summary receiver operating characteristic (SROC) curve’s area under the curve was 0.90. We found significant statistical heterogeneity between studies (for sensitivity, I 2 =94.22% (95% CI: 92.48-95.96), Q=294.11, P 2 =88.98% (95% CI: 84.95-93.01), Q=154.26, P <0.01. Conclusion: Given its high sensitivity, MCG has a high value for diagnosing CHD, especially in primary screening. Further investigation is required to examine additional factors that may affect the performance of MCG considering the limited clinical trials and sample size.
Open AccessMagnetocardiography for the diagnosis of coronary artery disease: a systematic review and meta-analysis
Background: Globally, coronary heart disease (CHD) is a major public health issue because it significantly increases mortality and medical expenses. In the recent years, magnetocardiography (MCG) has shown its potential as a new tool for diagnosing CHD. However, the quantitative assessment of MCG currently used for CHD diagnosis are insufficient, preventing its full integration into routine clinical practice. Methods: We searched PubMed (including MEDLINE), Embase, Web of Science, Cochrane Library, Scopus, China National Knowledge Infrastructure (CNKI), Wanfang Data, and ClinicalTrials.gov for studies published up to March 4, 2023. We systematically searched for studies that compare MCG (as the index test) with coronary angiography (as the standard reference) for diagnosing CHD in suspected population. Three authors assessed the quality of the included studies independently using the QUADAS-2 tool. We calculated the pooled value of the sensitivity and specificity of MCG using the bivariate model. To investigate clinical and methodological factors that might contribute to the statistical heterogeneity, we used meta-regression and subgroup analysis. This systematic review and meta-analysis has been conformed to PRISMA guidelines and registered with PROSPERO (number CRD42022332272). Results: By searching, we found 174 studies, 18 of them included 2,571 subjects from 6 countries and regions and met the inclusion criteria. The combined values for sensitivity and specificity are 86% (95% CI: 80-91) and 79% (95% CI: 71-86), respectively. The summary receiver operating characteristic (SROC) curve’s area under the curve was 0.90. We found significant statistical heterogeneity between studies (for sensitivity, I 2 =94.22% (95% CI: 92.48-95.96), Q=294.11, P 2 =88.98% (95% CI: 84.95-93.01), Q=154.26, P <0.01. Conclusion: Given its high sensitivity, MCG has a high value for diagnosing CHD, especially in primary screening. Further investigation is required to examine additional factors that may affect the performance of MCG considering the limited clinical trials and sample size.